Evotec has established a world-leading platform to support the discovery and validation of innovative disease modifying targets across different therapeutic areas as well as aid target deconvolution following a phenotypic screen.
The Company’s offering includes:
- Differential expression studies followed by bioinformatics-driven data mining and hypothesis building
- Gene knock-out and over-expression studies both in vitro and in vivo as well as access to relevant in vivo disease models
- World-class ex vivo imaging technology platform using tissue sections to study cellular and molecular events
- Phenotypic screening of complex cellular systems for hit identification
- Target deconvolution using proteomics
For more detailed information, please click on this link or contact us at email@example.com.